Pharmacy Billing — Specialty Drugs, Maximum Reimbursement

Proven Results

• 41% Average Revenue Increase
• 94.8% Clean Claim Rate
• 47% Reduction in Denials
• 21 Days Faster Payment Collection

Common Billing Challenges

Compound Formula Billing

Compounded medications require individual ingredient billing with proper HCPCS codes and quantities for each component.

Ingredient Cost Calculations

Calculating accurate ingredient costs, markups, and dispensing fees for compound medications is complex and time-consuming.

Prior Authorization Delays

Specialty medications and compounds require extensive prior authorizations with detailed clinical justification.

Specialty Drug Management

High-cost specialty medications require special handling, documentation, and payer-specific billing requirements.

DME-Linked Pharmacy Items

Items that cross pharmacy and DME categories require proper classification and billing under the correct benefit.

Payer-Specific Requirements

Each payer has unique requirements for compounded medications, specialty drugs, and pharmacy billing.

Our Solutions

Compound Billing Experts

Our team specializes in compound medication billing with expertise in ingredient coding and formula calculations.

• Accurate ingredient HCPCS coding
• Proper quantity calculations
• Cost markup optimization
• Reduced compound denials

Specialty Pharmacy Management

Comprehensive management of specialty medication billing with payer-specific compliance and documentation.

• High-cost drug billing expertise
• Manufacturer assistance programs
• Copay assistance coordination
• Specialty payer knowledge

Prior Authorization System

Dedicated PA team with automated tracking ensures timely approvals for specialty and compound medications.

• Faster medication approvals
• Clinical documentation support
• Step therapy navigation
• Appeal support for denials

Ingredient Tracking Platform

Advanced system tracks ingredient costs, quantities, and proper billing for all compound formulations.

• Automated cost calculations
• Real-time pricing updates
• Formula library management
• Profitability analysis

Specialized Services

Compound Drug Billing

Expert billing for compounded medications with proper ingredient coding and cost calculations.

• Ingredient billing
• Formula tracking
• Cost optimization
• Compound documentation

Specialty Medications

Specialized billing for high-cost specialty drugs with manufacturer program coordination.

• Specialty drug billing
• Buy-and-bill services
• Copay assistance
• Manufacturer rebates

DME-Linked Pharmacy

Expert billing for pharmacy items that qualify under DME benefits with proper classification.

• Nebulizer medications
• Diabetic supplies
• Enteral nutrition
• Ostomy supplies

Prior Authorization

Complete PA management for specialty and compound medications with clinical support.

• PA submission
• Clinical documentation
• Step therapy appeals
• Formulary management

Common CPT Codes Reference

Key codes include J2250 (Injection, midazolam, per 1 mg), J0897 (Denosumab, 1 mg (Prolia/Xgeva)), J9310 (Rituximab, 100 mg (Rituxan)), S5550 (Insulin, rapid onset, per 5 units), G8427 (Medication list documented in medical record by physician), 99605 (Medication therapy management, pharmacist, new patient, firs), 99606 (Medication therapy management, pharmacist, established patie), 99607 (MTM, pharmacist, each additional 15 min), J3490 (Unclassified drugs), Q4081 (Injection, epoetin alfa, 100 units (for ESRD patients)). Proper code selection requires understanding of bundling rules, NCCI edits, and modifier usage.

Expert Billing Insights

340B Drug Program: Eligibility, Operations, and Billing Compliance

The 340B Drug Pricing Program allows eligible covered entities (hospitals, FQHCs, Ryan White clinics, disproportionate share hospitals) to purchase outpatient drugs at significantly reduced prices — often 20–50% below wholesale. The financial benefit comes from the spread between 340B acquisition cost and standard reimbursement. However, 340B compliance requires rigorous split-billing systems to prevent diversion (340B drugs to non-eligible patients) or duplication (same drug claim under both 340B and Medicaid rebate). The program is under increasing regulatory scrutiny.

• 340B eligibility: FQHCs, Ryan White clinics, DSH hospitals, children's hospitals, hemophilia treatment centers
• Split billing required: 340B drug dispensed only to eligible patients from covered entity prescriptions
• Medicaid exclusion: 340B drugs cannot receive Medicaid drug rebates — requires Medicaid carve-out
• Contract pharmacy: many 340B entities use community pharmacies — audit trail required for compliance

Specialty Pharmacy Billing: Prior Authorization and Specialty Drug Management

Specialty pharmaceuticals — including biologics, oncologics, antiretrovirals, and immune modulators — are increasingly managed through specialty pharmacy channels due to their high cost, complex storage requirements, and patient monitoring needs. Buy-and-bill (physician purchases and administers drug) versus specialty pharmacy (drug dispensed by external pharmacy to patient) creates distinct billing pathways. Understanding which drugs fall under Part B (administered in clinical settings) versus Part D (self-administered) is critical.

• Part B drugs: infused, injected, or instilled in clinical setting — physician or outpatient bills
• Part D drugs: oral, self-injectable biologics (e.g., adalimumab pen, etanercept) — pharmacy bills
• REMS programs: mandatory for high-risk drugs — document enrollment and counseling compliance
• Biosimilar substitution: payers may require generic/biosimilar before brand biologic — document medical necessity for brand

Medication Therapy Management (MTM) Billing by Pharmacists

Medicare Part D-sponsored Medication Therapy Management programs provide comprehensive medication reviews to high-risk beneficiaries. Eligible pharmacists and physicians can bill for MTM services using the 99605/99606/99607 codes. The comprehensive medication review (CMR) includes all prescription and OTC medications, supplements, and herbal products. MTM is increasingly offered by integrated health systems and accountable care organizations as a quality improvement and cost-reduction strategy.

• CMR (comprehensive medication review): annual face-to-face or telehealth session — document all medications
• Targeted medication review (TMR): quarterly follow-up between annual CMR visits
• MTM eligibility: ≥3 chronic conditions, ≥8 medications, and drug cost threshold per plan
• Interventions: document drug therapy problems identified and recommendations made to prescribers

Payer-Specific Billing Tips

Medicare Part D

• Part D covers self-administered drugs — not physician-administered biologics (those go to Part B)
• MTM: covered under Part D by the plan; pharmacist or physician may provide CMR
• Low-income subsidy (LIS): eligible beneficiaries have $0–$15 copays — verify per drug tier
• Coverage gap ("donut hole"): effectively closed under IRA 2022 — 25% max out-of-pocket for most drugs

Medicaid

• 340B Medicaid carve-out: must carve 340B drugs out of Medicaid rebate program — use split billing
• Medicaid specialty drug prior auth: step therapy and PA often required before brand biologics
• Generic substitution: Medicaid typically requires generics when available
• Supplemental rebate negotiations: state Medicaid programs negotiate additional rebates on top of statutory

Commercial Payers

• Formulary management: specialty drugs on Tier 4/5 have high cost-share — verify patient OOP burden
• Specialty pharmacy designation: commercial plans route specialty drugs to preferred specialty pharmacies
• Step therapy override: for urgent medical need, step therapy waivers can be requested — document clinical rationale
• Prior authorization expiration tracking: specialty drug auths often expire annually — track renewal deadlines

Pharmacy Billing Best Practices

• NDC reporting: all drugs billed to commercial payers require NDC on claims — include lot and expiration
• Drug wastage documentation: bill wasted portions of single-dose vials with appropriate modifiers
• J-code currency: verify J-codes annually — codes change January 1 and July 1 each year
• Patient assistance programs (PAPs): manufacturer PAPs help uninsured/underinsured access biologics

Key Services

• pharmacy billing
• specialty pharmacy billing
• pharmaceutical billing
• pharmacy claim processing
• medication billing